Tissue-specific regulation of hnk-1 biosynthesis by bisecting glcnac

Human natural killer—1 (HNK-1) is a sulfated glyco-epitope regulating cell adhesion and synaptic functions. HNK-1 and its non-sulfated forms, which are specifically expressed in the brain and the kidney, respectively, are distinctly biosynthesized by two homologous glycosyltransferases: GlcAT-P in the brain and GlcAT-S in the kidney. However, it is largely unclear how the activity of these isozymes is regulated in vivo. We recently found that bisecting GlcNAc, a branching sugar in N-glycan, suppresses both GlcAT-P activity and HNK-1 expression in the brain. Here, we observed that the expression of non-sulfated HNK-1 in the kidney is unexpectedly unaltered in mutant mice lacking bisecting GlcNAc. This suggests that the biosynthesis of HNK-1 in the brain and the kidney are differentially regulated by bisecting GlcNAc. Mechanistically, in vitro activity assays demonstrated that bisecting GlcNAc inhibits the activity of GlcAT-P but not that of GlcAT-S. Furthermore, molecular dynamics simulation showed that GlcAT-P binds poorly to bisected N-glycan substrates, whereas GlcAT-S binds similarly to bisected and non-bisected N-glycans. These findings revealed the difference of the highly homologous isozymes for HNK-1 synthesis, highlighting the novel mechanism of the tissue-specific regulation of HNK-1 synthesis by bisecting GlcNAc

Measurement of forward neutral pion transverse momentum spectra for s\sqrt{s} = 7TeV proton-proton collisions at LHC

The inclusive production rate of neutral pions in the rapidity range greater than $y=8.9$ has been measured by the Large Hadron Collider forward (LHCf) experiment during LHC $\sqrt{s}=7$\,TeV proton-proton collision operation in early 2010. This paper presents the transverse momentum spectra of the neutral pions. The spectra from two independent LHCf detectors are consistent with each other and serve as a cross check of the data. The transverse momentum spectra are also compared with the predictions of several hadronic interaction models that are often used for high energy particle physics and for modeling ultra-high-energy cosmic-ray showers.Comment: 18 Pages, 10 figures, submitted to Phys. Rev.

The performance of the LHCf detector for hadronic showers

The Large Hadron Collider forward (LHCf) experiment has been designed to use the LHC to benchmark the hadronic interaction models used in cosmic-ray physics. The LHCf experiment measures neutral particles emitted in the very forward region of LHC collisions. In this paper, the performances of the LHCf detectors for hadronic showers was studied with MC simulations and beam tests. The detection efficiency for neutrons is from 60% to 70% above 500 GeV. The energy resolutions are about 40% and the position resolution is 0.1 to 1.3mm depend on the incident energy for neutrons. The energy scale determined by the MC simulations and the validity of the MC simulations were examined using 350 GeV proton beams at the CERN-SPS.Comment: 15pages, 19 figure

Measurement of zero degree single photon energy spectra for sqrt(s) = 7TeV proton-proton collisions at LHC

In early 2010, the Large Hadron Collider forward (LHCf) experiment measured very forward neutral particle spectra in LHC proton-proton collisions. From a limited data set taken under the best beam conditions (low beam-gas background and low occurance of pile-up events), the single photon spectra at sqrt(s)=7TeV and pseudo-rapidity (eta) ranges from 8.81 to 8.99 and from 10.94 to infinity were obtained for the first time and are reported in this paper. The spectra from two independent LHCf detectors are consistent with one another and serve as a cross check of the data. The photon spectra are also compared with the predictions of several hadron interaction models that are used extensively for modeling ultra high energy cosmic ray showers. Despite conservative estimates for the systematic errors, none of the models agree perfectly with the measurements. A notable difference is found between the data and the DPMJET 3.04 and PYTHIA 8.145 hadron interaction models above 2TeV where the models predict higher photon yield than the data. The QGSJET II-03 model predicts overall lower photon yield than the data, especially above 2TeV in the rapidity range 8.81<eta<8.99

Developing a High Resolution ZDC for the EIC

The Electron Ion Collider offers the opportunity to make un-paralleled multidimen- sional measurements of the spin structure of the proton and nuclei, as well as a study of the onset of partonic saturation at small Bjorken-x [1]. An important requirement of the physics program is the tagging of spectator neutrons and the identification of forward photons. We propose to design and build a Zero Degree Calorimeter, or ZDC, to measure photons and neutrons with excellent energy & position resolution

First results from LHCf for forward physics in √s = 7TeV proton-proton interactions

The LHCf Collaboration has completed the first step of its scheduled physics program for the study of emission of neutral particles in the forward region of proton-proton (pp) interactions at LHC. Between 2009 and 2010 the LHCf experiment has successfully taken data at 900 GeV and 7TeV total energy in the center-of-mass frame of reference (CM). After a short presentation of the experimental apparatus, the results for the γ-ray spectrum at √s = 7TeV are presented in this paper

Sinteza i biološko vrednovanje novih derivata 2-fenil-benzimidazol-1-acetamida kao potencijalnih anthelmintika

The present study describes synthesis of a series of 2-phenyl benzimidazole-1-acetamide derivatives and their evaluation for anthelmintic activity using Indian adult earthworms, Pheretima posthuma. The structure of the title compounds was elucidated by elemental analysis and spectral data. The compounds 4-({[2-(4-nitrophenyl)-1H-benzimidazol-1-yl]acetyl}amino) benzoic acid (3a), N-ethyl-2-[2-(4-nitrophenyl)-1H-benzimidazol-1-yl] acetamide (3c), N-benzyl-2-[2-(4-nitrophenyl)-1H-benzimidazol-1-yl] acetamide (3d), N-(4-hydroxyphenyl)-2-[2-(4-nitrophenyl)-1H-benzimidazol-1-yl] acetamide (3f), 2-[2-(4-nitrophenyl)-1H-benzimidazol-1-yl]-N-phenylacetamide (3h), 2-[2-(4-chlorophenyl)-1H-benzimidazol-1-yl]-N\u27-phenylacetohydrazide (3k), 2-[2-(4-chlorophenyl)-1H-benzimidazol-1-yl]-N-(4-nitrophenyl) acetamide (3n) and 2-[2-(4-chlorophenyl)-1H-benzimidazol-1-yl]-N-phenylacetamide (3q) were better to paralyze worms whereas N-ethyl-2-[2-(4-nitrophenyl)-1H-benzimidazol-1-yl] acetamide (3c), N-(4-nitrophenyl)-2-[2-(4-nitrophenyl)-1H-benzimidazol-1yl] acetamide (3e), 4-({[2-(4-chlorophenyl)-1H-benzimidazol-1-yl] acetyl} amino) benzoic acid (3j), 2-[2-(4-chlorophenyl)-1H-benzimidazol-1-yl]-N-ethylacetamide (3l) and 2-[2-(4-chlorophenyl)-1H-benzimidazol-1-yl]-N-phenylacetamide (3q) were better to cause death of worms compared to the anthelmintic drug albendazole.U radu je opisana sinteza derivata 2-fenil-benzimidazol-1-acetamida i ispitivanje njihovog anthelmintičkog djelovanja na odrasle indijske gliste, Pheretima posthuma. Struktura sintetiziranih spojeva određena je elementarnom analizom i spektroskopskim metodama. Spojevi 4-({[2-(4-nitrofenil)-1H-benzimidazol-1-il]acetil}amino) benzojeva kiselina (3a), N-etil-2-[2-(4-nitrofenil)-1H-benzimidazol-1-il] acetamid (3c), N-benzil-2-[2-(4-nitrofenil)-1H-benzimidazol-1-il] acetamid (3d), N-(4-hidroksifenil)-2-[2-(4-nitrofenil)-1H-benzimidazol-1-il] acetamid (3f), 2-[2-(4-nitrofenil)-1H-benzimidazol-1-il]-N-fenilacetamid (3h), 2-[2-(4-klorfenil)-1H-benzimidazol-1-il]-N\u27-fenilacetohidrazid (3k), 2-[2-(4-klorfenil)-1H-benzimidazol-1-il]-N-(4-nitrofenil) acetamid (3n) i 2-[2-(4-klorfenil)-1H-benzimidazol-1-il]-N-fenilacetamid (3q) jače paraliziraju gliste, a N-etil-2-[2-(4-nitrofenil)-1H-benzimidazol-1-il] acetamid (3c), 2-[2-(4-nitrofenil)-1H-benzimidazol-1-il]-N-fenilacetamid (3h), 4-({[2-(4-klorfenil)-1H-benzimidazol-1-il]acetil}amino) benzojeva kiselina (3j), 2-[2-(4-klorfenil)-1H-benzimidazol-1-il]-N-etilacetamid (3l) i 2-[2-(4-klorfenil)-1H-benzimidazol-1-il]-N-fenilacetamid (3q) učinkovitije usmrćuju gliste nego anthelmintik albendazol

Nasopharyngeal pneumococcal carriage in South Asian infants:Results of observational cohort studies in vaccinated and unvaccinated populations

BACKGROUND: Nasopharyngeal pneumococcal carriage (NPC) is a prerequisite for invasive pneumococcal disease and reduced carriage of vaccine serotypes is a marker for the protection offered by the pneumococcal conjugate vaccine (PCV). The present study reports NPC during the first year of life in a vaccinated (with PCV10) cohort in Bangladesh and an unvaccinated cohort in India. METHODS: A total of 450 and 459 infants were recruited from India and Bangladesh respectively within 0-7 days after birth. Nasopharyngeal swabs were collected at baseline, 18 and 36 weeks after birth. The swabs were processed for pneumococcal culture and identification of serotypes by the Quellung test and polymerase chain reaction (PCR). An identical protocol was applied at both sites. RESULTS: Prevalence of NPC was 48% in the Indian and 54.8% in the Bangladeshi cohort at 18 weeks. It increased to 53% and 64.8% respectively at 36 weeks. The average prevalence of vaccine serotypes was higher in the Indian cohort (17.8% vs 9.8% for PCV-10 and 26.1% vs17.6% for PCV-13) with 6A, 6B, 19F, 23F, and 19A as the common serotypes. On the other hand, the prevalence of non-vaccine serotypes was higher (43.6% vs 27.1% for non-PCV13) in the Bangladeshi cohort with 34, 15B, 17F, and 35B as the common serotypes. Overcrowding was associated with increased risk of pneumococcal carriage. The present PCV-13 vaccine would cover 28%-30% and 47%-48% serotypes in the Bangladeshi and Indian cohorts respectively. CONCLUSIONS: South Asian infants get colonised with pneumococci early in infancy; predominantly vaccine serotypes in PCV naïve population (India) and non-vaccine serotypes in the vaccinated population (Bangladesh). These local findings are important to inform the public health policy and the development of higher valent pneumococcal vaccines

Results from the LHCf experiment

LHCf is an experiment designed to study the very forward emission of neutral particles produced in collisions at the LHC. Its results can be used to calibrate the hadron interaction models of the Monte Carlo codes which allow the interpretation of energy spectrum and composition of high-energy cosmic rays as measured by air shower ground detectors. The experiment has already completed taking data in proton-proton collisions at √s = 900 GeV and at √s = 7TeV during 2009 and 2010. The detectors are now being upgraded and they will be installed again in the LHC tunnel for proton-ion collisions and for operation with protons at √s = 14TeV. In this paper results and comparisons with the predictions obtained from Monte Carlo simulations will be reported

Comparison of hadron interaction models with measurement of forward spectra by the LHCf apparatus

The LHCf experiment is a forward experiment of LHC. The two LHCf detectors, each composed of a pair of sampling and imaging calorimeters, have been installed at the forward region of IP1 to measure energy and transverse momentum spectra of neutral particles emitted in the very forward region of LHC collisions (η > 8.4). The operation at 900 GeV and 7TeV pp collisions has been completed in the middle of July 2010. We present some preliminary results in this paper